Detalhe da pesquisa
1.
Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study.
Front Med (Lausanne)
; 10: 1122367, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035317
2.
Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing Literature.
J Clin Med
; 11(15)2022 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35956159